These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29531793)

  • 21. VEGF induces proliferation of human hair follicle dermal papilla cells through VEGFR-2-mediated activation of ERK.
    Li W; Man XY; Li CM; Chen JQ; Zhou J; Cai SQ; Lu ZF; Zheng M
    Exp Cell Res; 2012 Aug; 318(14):1633-40. PubMed ID: 22659165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
    Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
    J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis in a surgical sponge model.
    Park K; Amano H; Ito Y; Kashiwagi S; Yamazaki Y; Takeda A; Shibuya M; Kitasato H; Majima M
    Biomed Pharmacother; 2016 Mar; 78():140-149. PubMed ID: 26898435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
    Dardik R; Inbal A
    Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression.
    Mannell HK; Pircher J; Chaudhry DI; Alig SK; Koch EG; Mettler R; Pohl U; Krötz F
    Cardiovasc Res; 2012 Jan; 93(1):111-9. PubMed ID: 22002459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substrate stiffness heterogeneities disrupt endothelial barrier integrity in a micropillar model of heterogeneous vascular stiffening.
    VanderBurgh JA; Hotchkiss H; Potharazu A; Taufalele PV; Reinhart-King CA
    Integr Biol (Camb); 2018 Dec; 10(12):734-746. PubMed ID: 30382278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
    Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
    Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.
    Dias S; Hattori K; Zhu Z; Heissig B; Choy M; Lane W; Wu Y; Chadburn A; Hyjek E; Gill M; Hicklin DJ; Witte L; Moore MA; Rafii S
    J Clin Invest; 2000 Aug; 106(4):511-21. PubMed ID: 10953026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells.
    Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K
    Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.
    Endo A; Fukuhara S; Masuda M; Ohmori T; Mochizuki N
    J Recept Signal Transduct Res; 2003; 23(2-3):239-54. PubMed ID: 14626450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional significance of vascular endothelial growth factor receptor expression on human glioma cells.
    Mentlein R; Forstreuter F; Mehdorn HM; Held-Feindt J
    J Neurooncol; 2004; 67(1-2):9-18. PubMed ID: 15072443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin-like domain 4-mediated ligand-independent dimerization triggers VEGFR-2 activation in HUVECs and VEGFR2-positive breast cancer cells.
    Zhang S; Gao X; Fu W; Li S; Yue L
    Breast Cancer Res Treat; 2017 Jun; 163(3):423-434. PubMed ID: 28303365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors.
    Lacal PM; Graziani G
    Pharmacol Res; 2018 Oct; 136():97-107. PubMed ID: 30170190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
    Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
    Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.
    Jayasinghe C; Simiantonaki N; Kirkpatrick CJ
    BMC Cancer; 2015 Mar; 15():104. PubMed ID: 25880726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
    Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
    Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Autocrine stimulation of receptor-tyrosine kinases (RTK) in human tumor cell lines in vitro: therapeutic implications].
    Gaumann A; Groot M; Drexler HC; Breier G
    Verh Dtsch Ges Pathol; 2003; 87():232-9. PubMed ID: 16888917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis.
    Lee WS; Pyun BJ; Kim SW; Shim SR; Nam JR; Yoo JY; Jin Y; Jin J; Kwon YG; Yun CO; Nam DH; Oh K; Lee DS; Lee SH; Yoo JS
    MAbs; 2015; 7(5):957-68. PubMed ID: 25942475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.